» Articles » PMID: 4598114

The Effect of Bacillus Calmette-Guerin-induced Macrophage Activation on the in Vivo Clearance of Sensitized Erythrocytes

Overview
Journal J Clin Invest
Specialty General Medicine
Date 1974 Jun 1
PMID 4598114
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

The clearance of (51)Cr-labeled guinea pig erythrocytes, sensitized with a known amount of IgM or IgG antibody, was examined in normal and BCG-infected guinea pigs. In normal animals, IgM-coated cells were rapidly sequestered in the liver. Most of these cells were then slowly released into the circulation where they survived normally as Coombs-positive erythrocytes. Neither the site nor extent of initial clearance showed major alterations in BCG-infected animals; however, there was no return of the sequestered erythrocytes into the circulation. This pattern of clearance was only seen in normals at very high levels of sensitization. In contrast to the IgM studies, the pattern of clearance of IgG-sensitized erythrocytes was not altered, but the rate and magnitude was markedly increased at all levels of sensitization. In addition, complement-independent clearance of IgG-sensitized erythrocytes was augmented in BCG-infected guinea pigs lacking classical complement pathway function. The spleen remained the organ primarily responsible for this increased clearance of IgG-sensitized erythrocytes. Sensitized cells in BCG-infected animals were removed from the circulation as if they were coated with several times the amount of antibody. Serum factors were shown not to be responsible for the increased clearance. These data suggest that increased macrophage activation in BCG-infected animals plays a critical role in determining the consequences of cell sensitization in vivo. These studies may help to explain exacerbations of hemolytic anemias and related states after intercurrent infections.

Citing Articles

Immunomodulatory effects of recombinant BCG expressing MSP-1C of Plasmodium falciparum on LPS- or LPS+IFN-γ-stimulated J774A.1 cells.

Mohamad D, Suppian R, Nor N Hum Vaccin Immunother. 2014; 10(7):1880-6.

PMID: 25424796 PMC: 4186016. DOI: 10.4161/hv.28695.


A targeted complement-dependent strategy to improve the outcome of mAb therapy, and characterization in a murine model of metastatic cancer.

Elvington M, Huang Y, Morgan B, Qiao F, van Rooijen N, Atkinson C Blood. 2012; 119(25):6043-51.

PMID: 22442351 PMC: 3383016. DOI: 10.1182/blood-2011-10-383232.


C5a and Fcgamma receptors: a mutual admiration society.

Atkinson J J Clin Invest. 2006; 116(2):304-6.

PMID: 16453017 PMC: 1359066. DOI: 10.1172/JCI27759.


Tumor-promoting phorbol esters stimulate C3b and C3b' receptor-mediated phagocytosis in cultured human monocytes.

Wright S, Silverstein S J Exp Med. 1982; 156(4):1149-64.

PMID: 7153708 PMC: 2186805. DOI: 10.1084/jem.156.4.1149.


Modification of glomerular immune complex deposition in mice by activation of the reticuloendothelial system.

Barcelli U, RADEMACHER R, Ooi Y, Ooi B J Clin Invest. 1981; 67(1):20-7.

PMID: 6450222 PMC: 371567. DOI: 10.1172/JCI110013.


References
1.
Benacerraf B, Thorbecke G, Jacoby D . Effect of zymosan on endotoxin toxicity in mice. Proc Soc Exp Biol Med. 1959; 100(4):796-9. DOI: 10.3181/00379727-100-24781. View

2.
Brown D, LACHMANN P, Dacie J . The in vivo behaviour of complement-coated red cells: studies in C6-deficient, C3-depleted and normal rabbits. Clin Exp Immunol. 1970; 7(3):401-21. PMC: 1712743. View

3.
Motulsky A, CASSERD F, GIBLETT E, BROUN Jr G, Finch C . Anemia and the spleen. N Engl J Med. 1958; 259(25):1215-9 concl. DOI: 10.1056/NEJM195812182592506. View

4.
Gigli I, NELSON Jr R . Complement dependent immune phagocytosis. I. Requirements for C'1, C'4, C'2, C'3. Exp Cell Res. 1968; 51(1):45-67. DOI: 10.1016/0014-4827(68)90158-4. View

5.
Schreiber A, Frank M . Role of antibody and complement in the immune clearance and destruction of erythrocytes. II. Molecular nature of IgG and IgM complement-fixing sites and effects of their interaction with serum. J Clin Invest. 1972; 51(3):583-9. PMC: 302164. DOI: 10.1172/JCI106847. View